Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fumarate versus methotrexate for severe psoriasis
NL-OMON21850Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Fumaderm and methotrexate in plaque psoriasis (2 arms), sponsored by Erasmus MC. Primary endpoint: PASI score. Started Sep 2006; status: active, not recruiting.
02
Drugs
Fumadermmethotrexate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NL-OMON21850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21850.